The clinical significance of incidental intra-abdominal findings on positron emission tomography performed to investigate pulmonary nodules
Open Access
- 27 January 2012
- journal article
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 10 (1) , 25
Abstract
Lung cancer is a common cause of cancer-related death. Staging typically includes positron emission tomography (PET) scanning, in which18F-fluoro-2-dexoy-D-glucose (FDG) is taken up by cells proportional to metabolic activity, thus aiding in differentiating benign and malignant pulmonary nodules. Uptake of FDG can also occur in the abdomen. The clinical significance of incidental intraabdominal FDG uptake in the setting of pulmonary nodules is not well established. Our objective was to report on the clinical significance of incidental intra-abdominal FDG activity in the setting of lung cancer.Keywords
This publication has 17 references indexed in Scilit:
- Ability of integrated positron emission and computed tomography to detect significant colonic pathologyCancer, 2010
- Incidental PET/CT findings in the cancer patient: How should they be managed?Surgery, 2009
- Role of Low-dose, Noncontrast Computed Tomography from Integrated Positron Emission Tomography/Computed Tomography in Evaluating Incidental 2-Deoxy-2-[F-18]fluoro-d-glucose-avid Colon LesionsMolecular Imaging and Biology, 2007
- Extrathoracic PET/CT Findings in Thoracic MalignanciesJournal of Thoracic Imaging, 2006
- Detection of Clinically Unexpected Malignant and Premalignant Tumors with Whole-Body FDG PET: Histopathologic ComparisonRadiology, 2004
- Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non–small cell lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 2003
- Outcomes in Older People Undergoing Operative Intervention for Colorectal CancerJournal of the American Geriatrics Society, 2001
- An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer.2001
- Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings.Radiology, 1998
- Labeled 2‐deoxy‐D‐glucose analogs. 18F‐labeled 2‐deoxy‐2‐fluoro‐D‐glucose, 2‐deoxy‐2‐fluoro‐D‐mannose and 14C‐2‐deoxy‐2‐fluoro‐D‐glucoseJournal of Labelled Compounds and Radiopharmaceuticals, 1978